Pathology Doctors in Morrisville, NC Accepting Medicare

4 Pathology doctors found. Showing 1 - 4

Dr. Matthew Plymyer, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Perimeter Park Dr Ste C, Morrisville, NC 27560 Phone: 919-589-2520    Fax: 984-239-2619

Dr. Garron Joseph Solomon, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 627 Davis Dr, Suite 600, Morrisville, NC 27560 Phone: 919-237-1432    Fax: 919-800-3650

Claire Hozier Edgerly, MD Pathology - Molecular Genetic Pathology Medicare: Medicare Enrolled Practice Location: 7010 Kit Creek Rd, Morrisville, NC 27560 Phone: 919-748-5929

Dr. Nimesh R. Patel, M.D. Pathology - Molecular Genetic Pathology Medicare: Medicare Enrolled Practice Location: 7010 Kit Creek Rd # 229, Morrisville, NC 27560 Phone: 888-988-3639

News Archive

Landauer announces GPS acquisition

Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring services, today announced the completion of two acquisitions in accordance with its long-term strategic priorities.

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.

No added benefit from linagliptin in patients with type 2 diabetes

Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.

Study shows link between history of gum disease and increased cancer risk in older women

Postmenopausal women who have a history of gum disease also have a higher risk of cancer, according to a new study of more than 65,000 women.

Read more Medical News

› Verified 3 days ago